223
induction of
FIG. 6. Oxidative
agonist-induced
drawn native
Freshly
fragmentation.
platelet
=
5) wasincubated
from
whole blood
donors
(n
TOfor minuteat37’C.
3 mMchloramine
1
at 0 to
adenosine
10
or
Then,
monds)
diphosphate (dia-
activator
thrombin
pM
6.25
~M
receptor
andthe mixtures
were
added,
37°C.
at
minutes
were incub~t~d
’
for
3
incubated
were
Fifty-
blood werefixed
After re-
microliter
of activated
aliquots
1 ~l~
in
moval
bated
1,000
para-formaidehyde.
pL
were incu-
anti-CD62P-PE
the
of the
fixative,
samples
‘
with anti-CD61-FITC and
for
con-
flow
and
formation of
antibodies
the
trol value
analyzed
cytometry
by
(100%
platelet fragments
=
=
Conc.
mM
0
chloramine
added).
concentration.
B&dquo;1111B,11&dquo;1
’.’ vmVIGlHlUv....VII.....
&dquo;,
I
Selectins
activation.
released to the
surface
upon
in
role
platelet
NEngl Med
by neutrophils.
J
destruction
1989;
Weiss SJ.
320:365.
Stief TW,
of
interaction
2.
3.
Tissue
the
an
important
mediating
or
play
with
(9-11).
platelet
(PMN
monocytes)
phagocytes
platelets
Nonradical oxidants
et al.
of
Stief MH, Ehrenthal W,
induce
the
PMN
can activate
Activated
thus,
(12);
uro-
platelets
the activation
of plasmatic single-chain
phagocyte type
kinase.
Thromb Res 1991;64:597.
of activated
An
a
main activation
by
product
regulation
N.
of nitric
Reaction
Woolf
MM.
AA, Epperlein
Noronha-Dutra
4.
is
of
PMN,
importance.
physiologic
singlet oxygen,
to
with
oxide
potentially cytotoxic
produce
peroxide
hydrogen
an en-
results in
often
enhanced cell-cell interaction
for
as
nitric
a model
oxide-mediated
FEBS
killing.
oxygen
1993;321:59.
Di Mascio
singlet
Lett
of
~ han~~d
(13).
singlet oxygen
generation
et al.
Bechara
Medeiros
molecular
hydrogen
5.
6.
EJ,
in the reaction
MH,
P,
Singlet
mMHOllchloramines
generate upto 5
of
for inhibition of the formation
Activated PMN
I
with
of
peroxynitrite
oxygen production
The
(2).
platelet
ED5(,
1994;355:287.
generation
FEBS Lett
peroxide.
1 delta
the
activated PMN
of
is
I
mM.Consequently,
Khan AU.
to 1.5
(
Quantitative
singlet
g) oxygen
aggregates
of
reaction
from
nitric oxide and
10:329.
acidified
by
aqueous peroxynitrite produced
inhibit
be able to
thrombocytes by
efficiently
should
anion.
Biolumin Chemilumin 1995;
superoxide
is
that
means of the nonradical oxidant
singlet oxygen
or chloramines
with
et al. Human neutro-
RJ,
of
DeNucci
RJ,
HOCI
7. Salvemini
D,
Gryglewski
inhibit
interactions
releas-
and
cells
mononuclear
by
aggregation
platelet
phils
(Mallet reaction) l,14-16, i?).
hydrogen peroxide
USA
like
Natl
Acad
oxide
Sci
1989;86:
a nitric
factor. Proc
ing
the
is
methionine or
In
cysteine
singlet ~~y~~n;
or cholesterol couldinteract with
main physi-
proteins,
6328.
I
unsatu-
also
8.
9.
et al. Singlet oxygen (1O)2inactivates
of
reaction
Kurz
J. Doss MO,
Stief TW,
partners
ologic
rated
and
X
Factor
Factor
VIII,
Factor V,
platelet aggrega-
fibrinogen,
acids
singlet
fatty
Thromb
tion ofhuman
blood.
Celi
A,
2000;97:473.
reaction
the exact
Therefore,
(18,19).
although
in
oxygen
a
et al. PADGEM
Gilbert
Larsen
GE,
E,
that mediates
Cell
protein:
receptor
and
to be
remains
for
with
of
the interaction
1989;59:305.
Kotowicz
neutrophils
platelets
et al.
receptor
established,
singlet oxygen
platelets
monocytes.
10. Peters
be
candidates could
oxygen-
singlet
possible
functionally
KT,
MJ, Dixon G,
Circulating platelet-
of activated neu-
as
such
proteins
important
susceptible,
a
represent
subpopulation
complexes
for
neutrophil
factor
von Willebrand
of the
GP Mb/ma
and intracellular
(8),
me-
kill-
(20),
or
adhesion,
phagocytosis
fibrinogen,
primed
trophils
J
Haematol1999;106:391.
JM,
Br
ing.
or
intermediates
prostaglandin
enzymes
et al. Selectins in
the
11.
Fareed
HIT
S19e9m9i;n25T(hSruopmpbl H1e)m:o3s7t.
DA,
and
J,
Hoppensteadt
Walenga
t~6c~Iis~n of
(21-23).
inhibits
platelets
role
modulation.
therapeutic
syndrome: pathophysiologic
the ex-
In
conclusion,
decreasing
platelets,
102
et al. Contact-induced
Maras
A,
in human
12. Ruf
Schlenk
RF,
A,
activation
neutrophil
andtheformationof
of
is thatactivated
CD62P
aggregate
hemostasis,
. pr~ssi~rn
platelet
and
cells
whole
suspensions
by platelets
modulate
The
IIt~
blood.
1992;80:1238.
antidirombotic state.
into an
~si1.ed~
1I&dquo;tiV~,.d.~MN.. ,’,
al.
physiologic sig-
t
t
~
Y
,
:n1 salf
action of
13.
DC,et
SB, Toman C, Anderson
Adherence-dependent
Shappell
mod.U~ ?e.fl1O~~j,S’
is
Mac-1
secretion
mediated
by
chlo-
and
direct
neutrophil hydrogen peroxide
(released
by
102
anticoagulant
J
Immunol 1989;144:2702.
(CD11b/18).
be
a new
ramines
as
such
might
principle
vancomycin)
in
X.
Mao
Y,
the
14.
15.
L, Shi
superox-
B19i l I2n27t.
Singlet9oo5xy;g3en6g:eneration
Zang
intervention in atherothrombosis.
for pharmacologic
Mol
ide
r
e
i
a
o
c
c
ti
h
o
e
n
m.
et al.
oxidant in
Hori
T,
Tatsuzawa
K,
H,
Singlet oxygen
myeloperoxidase-
Maruyama
for
Baker
Lara
thank
Theauthors
expert
Acknowledgement
I
as the
principal
([1]Delta[g]O[2])
technical assistance.
assistance.
Biochem
Bio-
in
p1h9y9s9;R2e6s2C:o6m4m7u.n
bacterial
mediated
neutrophil phagosome.
killing
REFERENCES
’1 ’technical,
et al.
16.
J,
C, Makiuchi M,
Physiological production
Miyazaki
Kiryu
in the
of
1.
factor
Fareed J. Theantithrombotic
system.
myeloperoxidase-H2O2-chloride
oxygen
F19singlet
E9B9;S443L:e15t4t.
Stief TW,
/hv).
oxygen/light
singlet
Clin
Thromb/Hemost 2000;6:22.
Appl